Header Logo

Connection

Bruce Fireman to Haemophilus Vaccines

This is a "connection" page, showing publications Bruce Fireman has written about Haemophilus Vaccines.
Connection Strength

0.455
  1. Determining Which of Several Simultaneously Administered Vaccines Increase Risk of an Adverse Event. Drug Saf. 2020 10; 43(10):1057-1065.
    View in: PubMed
    Score: 0.183
  2. Efficacy of Haemophilus influenzae type b capsular polysaccharide vaccine. Pediatr Infect Dis J. 1988 Mar; 7(3):149-56.
    View in: PubMed
    Score: 0.077
  3. Lack of association between receipt of conjugate haemophilus influenzae type B vaccine (HbOC) in infancy and risk of type 1 (juvenile onset) diabetes: long term follow-up of the HbOC efficacy trial cohort. Pediatr Infect Dis J. 2002 Jun; 21(6):568-9.
    View in: PubMed
    Score: 0.051
  4. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J. 1999 Sep; 18(9):757-63.
    View in: PubMed
    Score: 0.043
  5. Safety of combined oligosaccharide conjugate Haemophilus influenzae type b (HbOC) and whole cell diphtheria-tetanus toxoids-pertussis vaccine in infancy. The Kaiser Permanente Pediatric Vaccine Study Group. Pediatr Infect Dis J. 1993 Dec; 12(12):981-5.
    View in: PubMed
    Score: 0.029
  6. Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use. J Infect Dis. 1992 Jun; 165 Suppl 1:S139-43.
    View in: PubMed
    Score: 0.026
  7. Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Pediatr Infect Dis J. 1991 Feb; 10(2):92-6.
    View in: PubMed
    Score: 0.023
  8. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Pediatr Infect Dis J. 1991 Feb; 10(2):97-104.
    View in: PubMed
    Score: 0.023

© 2024 Kaiser Permanente